AN UNBIASED VIEW OF LINK ALTERNATIF MBL77

Not all patients with CLL need therapy. Inspite of all recent advancements, the iwCLL nonetheless recommends watchful observation for patients with asymptomatic sickness.86 This recommendation relies on no less than two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).1